Patents by Inventor Bo Åkerström

Bo Åkerström has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ALPHA-1-MICROGLOBULIN FOR PROTECTION OF BONE MARROW CELLS
    Publication number: 20200345810
    Abstract: The present invention relates to alpha-1-microglobulin (A1M) for use in the protection of bone marrow cells in a subject.
    Type: Application
    Filed: November 1, 2018
    Publication date: November 5, 2020
    Inventors: Johan Flygare, Eddie Thordarson, Bo Åkerström, Magnus Göran Gram
  • ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA
    Publication number: 20190054142
    Abstract: This invention relates to an alpha-1-microglobulin for use in prevention of contras medium nephropathy.
    Type: Application
    Filed: February 24, 2017
    Publication date: February 21, 2019
    Applicant: A1M Pharma AB
    Inventors: Martin AUSTIN, Magnus Göran GRAM, Bo ÅKERSTRÖM
  • DIAGNOSIS AND TREATMENT OF PREECLAMPSIA
    Publication number: 20180284087
    Abstract: The present invention relates to biomarkers for preeclampsia as well as treatment of this disease. In particular, the invention relates to methods for diagnosis or aiding in the diagnosis of preeclampsia of a pregnant female mammal to detect elevated levels of free haemoglobin, particularly free fetal haemoglobin. This facilitates and makes possible early diagnosis and clinical intervention when a preeclamptic condition is found. In addition, the invention relates to a method to treat female mammals with preeclampsia with the purpose to reverse the pathological conditions associated with this disease.
    Type: Application
    Filed: January 26, 2018
    Publication date: October 4, 2018
    Applicant: A1M Pharma AB
    Inventors: Stephan HANSSON, Bo ÅKERSTRÖM
  • MEDICAL USE OF THE RADICAL SCAVENGER AND ANTIOXIDANT ALPHA-1-MICROGLOBULIN
    Publication number: 20110190208
    Abstract: Medical use of alpha-1-microglobulin (A1M) in the treatment or prophylaxis of diseases wherein oxidative stress is a responsible factor in the progress of the disease. Notably, the present invention relates to the medical use of alpha-1-microglobulin in the treatment or prophylaxis of diseases or conditions associated with the presences of free radicals and/or free haemoglobin in the subject.
    Type: Application
    Filed: July 17, 2009
    Publication date: August 4, 2011
    Inventors: Bo Åkerström, Stefan Hanson, Martin Lennarth Olsson, Magnus Olsson